SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?
🔹 Sponsor:
Use the code "CORE30" for 30% off:Â https://www.coreimpodcast.com/MKSAP
🔹 Transcript and Show Notes
Timestamps:
(01:42) | Starting Treatment for Newly Diagnosed Type 2 Diabetes
(08:40) | Balancing Cost, Coverage, and First-Line Therapy Choices
(13:44) | Choosing Therapy for CAD and CKD: The Case for SGLT2 vs. GLP-1
(19:42) | Managing Obesity, Sleep Apnea, and Pain in Diabetes Care
(27:57) | Rethinking Sulfonylureas and Shifting Toward Modern Agents
(29:07) | Choosing Between GLP-1 and SGLT2 Inhibitors for Comorbidities
(35:34) | Weighing Side Effects and Practical Use of GLP-1 and SGLT2 Inhibitors
Tags: CoreIM, Primary Care, Endocrinology, Diabetes Mellitus, Type 2 Diabetes, Type 1 Diabetes, Metformin, GLP-1, SGLT2, Insulin, CGM, A1C, DKA, Medical Education, Clinical Reasoning, Hospital Medicine
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out Branch Basics: https://branchbasics.com/COREIM and use the code CoreIM for 15%
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
* Check out Uncommon Goods: https://uncommongoods.com/COREIM
* Check out Washington Red Raspberries: https://redrazz.org
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
